Selling trial delivery capability, not a product.
Contract research organisations sell operational capability, therapeutic expertise and a track record of delivery, which means the site’s job is demonstrating competence and trust to sponsors evaluating who will actually run their trial.
A sponsor choosing a CRO is evaluating operational reliability as much as scientific capability, which means the site needs to demonstrate process, track record and therapeutic depth credibly, not just describe services in general terms.
Content structured around therapeutic and operational capability a sponsor can evaluate, case evidence where it can be shared, and a site architecture that helps a specific type of sponsor find the specific capability they need quickly.
Every case study is substantiated and shaped around the confidentiality your sponsor relationships require — we work with the level of detail you’re able to share, not the level that would make the best story.
The scope our work with CRO companies has operated within.
The build priorities for a services business differ from a product company. Here is what CRO companies most often need.
How this work is approached specifically for CRO.
What comes up when building for a contract research organisation.
Usually within limits set by your sponsor agreements, since most sponsor contracts restrict naming the study or compound even where the relationship itself is public. We favour credible generalised evidence — therapeutic area volume, enrolment speed, retention rates — over specific detail that cannot be substantiated publicly, which keeps the content defensible without breaching any confidentiality clause.
Yes — this is usually the first thing a sponsor’s feasibility team checks, so we build it as structured, filterable data rather than a static map graphic. Site count, therapeutic area coverage, and past enrolment performance by region can be presented in a format a sponsor can screenshot into their own vendor evaluation rather than needing to ask you directly.
Yes — see clinical trial recruitment website for that specific build, which is typically a separate, patient-facing site linked from your corporate presence rather than a page within it. Keeping the two separate matters because a recruitment site needs different compliance review, a simpler reading level, and its own consent and eligibility screening flow.
Yes — a CRO operating across several countries typically needs the site network broken out by country with local contact details and language, rather than one global list a sponsor has to filter manually. We build that structure so adding a new country’s sites later is a content update, not a rebuild of the page.
Related sectors worth reviewing alongside CRO.
A capability story that needs to reach the sponsors actually evaluating it. Tell us your therapeutic focus and we will tell you how we would approach it for a CRO.